Antiphospholipid Syndrome and Pregnant @checkrare
Antiphospholipid Syndrome and Pregnant  @checkrare
Uploaded October 2026 | Updated November 2026, 4 hours ago
Jane Salmon, MD, Professor of Medicine at Weill Cornell Medical College, discusses antiphospholipid syndrome (APS), its impact on pregnancy, and emerging research into Cimzia (certolizumab pegol) as a potential approach to preventing serious pregnancy complications.

View the full interview at checkrare.com/fda-grants-breakthrough-therapy-designation-to-cimzia-for-pregnancy-complications-in-antiphospholipid-syndrome
Antiphospholipid Syndrome and PregnantASCO 2026: MajesTEC-9 Clinical Trial ResultsTaletrectinib for ROS1-Positive Non-Small Cell Lung CancerBreakthrough Therapy Designation to Cimzia for Antiphospholipid SyndromeASCO 2026: CARTITUDE-4 Cytogenetic Subgroup AnalysisDermiselagon Development for EPP and XLPFDA Approves New Therapies for MPS IIIA and SMABreakthrough Therapy Designation to Cimzia for Pregnancy Complications in Antiphospholipid SyndromeEfficacy of Vosoritide to Treat HypochondroplasiaCh 5: Urgency of Diagnosis and Treatment in C3GAddressing Patient Experiences With IgA NephropathyCommon Concerns in Patients With Fabry Disease
CheckRare |

Antiphospholipid Syndrome and Pregnant

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER